Abstract:MicroRNAs can promote translation of specific mRNAs in quiescent (G0) mammalian cells and immature Xenopus laevis oocytes. We report that microRNA-mediated upregulation of target mRNAs in oocytes is dependent on nuclear entry of the microRNA; cytoplasmically-injected microRNA repress target mRNAs. Components of the activation microRNP, AGO, FXR1 (FXR1-iso-a) and miR16 are present in the nucleus and cytoplasm. Importantly, microRNA target mRNAs for upregulation, Myt1, TNFα and a reporter bearing the TNFα AU-ric… Show more
“…29 In proliferating cells, FXR1a overexpression leads to microRNA mediated translation activation. 75 Consistently, proteomic studies in FXR1 depleted cells revealed decrease in protein levels of certain mRNAs that are targets of activation and require FXR1 for their polysome association. 31 Third, FXR1 does not interact with GW182 and does not lead to repression but instead promotes activation of translation.…”
Section: Critical Features Of Fxr1a-micrornp Mediated Translationmentioning
confidence: 68%
“…25,31,75 Several intriguing questions emerge from these studies and remain to be addressed. First, it is not known how FXR1a-microRNP selects its targets for activation in G0.…”
Section: Future Questionsmentioning
confidence: 99%
“…Consistently, we find that Cyclin E mRNA that is not recruited by FXR1a-microRNP in the nucleus, is repressed in G0. 31,75,120 How specific microRNAs are recruited to this complex remain to be ascertained. Fifth, mRNAs recruited by the FXR1a-microRNP need to have short poly(A) tails to avoid PABP and thereby, avoid repression by GW182 and canonical translation that is inhibited in these conditions.…”
Section: Critical Features Of Fxr1a-micrornp Mediated Translationmentioning
confidence: 99%
“…75 FXR1a-microRNP activates translation of reporter mRNAs bearing microRNA target sites in the 3 0 UTR, and of specific endogenous mRNAs like TNFa and MYT1 in G0 mammalian cells and Xenopus immature oocytes respectively. 17,25,31 Proliferating THP1 cells, treated with mTOR inhibitor Torin1 that blocks 4EBP phosphorylation and thereby, canonical translation-recreating conditions similar to G0 cells-show microRNA mediated translation activation of reporter mRNAs.…”
“…29,31 In G0 and distinct oocyte stages, 115,116 the association of repressor GW182 protein with AGO2 may be reduced, 114,117-119 which may permit activation of specific mRNAs. Fourth, in order to get translation activation, target mRNAs and the microRNAs in quiescent conditions have to be recruited in the nucleus 75 by AGO2 and FXR1. mRNAs not associated in the nucleus with the FXR1a-microRNP are not translationally upregulated, and could be subject to repression by the canonical microRNP.…”
Section: Critical Features Of Fxr1a-micrornp Mediated Translationmentioning
Eukaryotic protein synthesis is a multifaceted process that requires coordination of a set of translation factors in a particular cellular state. During normal growth and proliferation, cells generally make their proteome via conventional translation that utilizes canonical translation factors. When faced with environmental stress such as growth factor deprivation, or in response to biological cues such as developmental signals, cells can reduce canonical translation. In this situation, cells adapt alternative modes of translation to make specific proteins necessary for required biological functions under these distinct conditions. To date, a number of alternative translation mechanisms have been reported, which include non-canonical, cap dependent translation and cap independent translation such as IRES mediated translation. Here, we discuss one of the alternative modes of translation mediated by a specialized microRNA complex, FXR1a-microRNP that promotes non-canonical, cap dependent translation in quiescent conditions, where canonical translation is reduced due to low mTOR activity.
“…29 In proliferating cells, FXR1a overexpression leads to microRNA mediated translation activation. 75 Consistently, proteomic studies in FXR1 depleted cells revealed decrease in protein levels of certain mRNAs that are targets of activation and require FXR1 for their polysome association. 31 Third, FXR1 does not interact with GW182 and does not lead to repression but instead promotes activation of translation.…”
Section: Critical Features Of Fxr1a-micrornp Mediated Translationmentioning
confidence: 68%
“…25,31,75 Several intriguing questions emerge from these studies and remain to be addressed. First, it is not known how FXR1a-microRNP selects its targets for activation in G0.…”
Section: Future Questionsmentioning
confidence: 99%
“…Consistently, we find that Cyclin E mRNA that is not recruited by FXR1a-microRNP in the nucleus, is repressed in G0. 31,75,120 How specific microRNAs are recruited to this complex remain to be ascertained. Fifth, mRNAs recruited by the FXR1a-microRNP need to have short poly(A) tails to avoid PABP and thereby, avoid repression by GW182 and canonical translation that is inhibited in these conditions.…”
Section: Critical Features Of Fxr1a-micrornp Mediated Translationmentioning
confidence: 99%
“…75 FXR1a-microRNP activates translation of reporter mRNAs bearing microRNA target sites in the 3 0 UTR, and of specific endogenous mRNAs like TNFa and MYT1 in G0 mammalian cells and Xenopus immature oocytes respectively. 17,25,31 Proliferating THP1 cells, treated with mTOR inhibitor Torin1 that blocks 4EBP phosphorylation and thereby, canonical translation-recreating conditions similar to G0 cells-show microRNA mediated translation activation of reporter mRNAs.…”
“…29,31 In G0 and distinct oocyte stages, 115,116 the association of repressor GW182 protein with AGO2 may be reduced, 114,117-119 which may permit activation of specific mRNAs. Fourth, in order to get translation activation, target mRNAs and the microRNAs in quiescent conditions have to be recruited in the nucleus 75 by AGO2 and FXR1. mRNAs not associated in the nucleus with the FXR1a-microRNP are not translationally upregulated, and could be subject to repression by the canonical microRNP.…”
Section: Critical Features Of Fxr1a-micrornp Mediated Translationmentioning
Eukaryotic protein synthesis is a multifaceted process that requires coordination of a set of translation factors in a particular cellular state. During normal growth and proliferation, cells generally make their proteome via conventional translation that utilizes canonical translation factors. When faced with environmental stress such as growth factor deprivation, or in response to biological cues such as developmental signals, cells can reduce canonical translation. In this situation, cells adapt alternative modes of translation to make specific proteins necessary for required biological functions under these distinct conditions. To date, a number of alternative translation mechanisms have been reported, which include non-canonical, cap dependent translation and cap independent translation such as IRES mediated translation. Here, we discuss one of the alternative modes of translation mediated by a specialized microRNA complex, FXR1a-microRNP that promotes non-canonical, cap dependent translation in quiescent conditions, where canonical translation is reduced due to low mTOR activity.
Diffuse invasion is the primary cause of treatment failure of glioblastoma (GBM). Previous studies on GBM invasionhave long been forced to use the resected tumor mass cells. Here, a strategy to reliably isolate matching pairs of invasive (GBM INV ) and tumor core (GBM TC ) cells from the brains of 6 highly invasive patient-derived orthotopic models is described. Direct comparison of these GBM INV and GBM TC cells reveals a significantly elevated invasion capacity in GBM INV cells, detects 23/768 miRNAs over-expressed in the GBM INV cells (miRNA INV ) and 22/768 in the GBM TC cells (miRNA TC ), respectively. Silencing the top 3 miRNAs INV (miR-126, miR-369-5p, miR-487b) successfully blocks invasion of GBM INV cells in vitro and in mouse brains. Integrated analysis with mRNA expression identifies miRNA INV target genes and discovers KCNA1 as the sole common computational target gene of which 3 inhibitors significantly suppress invasion in vitro. Furthermore, in vivo treatment with 4-aminopyridine (4-AP) effectively eliminates GBM invasion and significantly prolongs animal survival times (P = 0.035). The results highlight the power of spatial dissection of functionally accurate GBM INV and GBM TC cells in identifying novel drivers of GBM invasion and provide strong rationale to support the use of biologically accurate starting materials in understanding cancer invasion and metastasis.
Recent studies have shown that short non-coding RNAs, known as microRNAs (miR-NAs) and their dysregulation, are implicated in the pathogenesis of acute myeloid leukaemia (AML). This is due to their role in the control of gene expression in a variety of molecular pathways. Therapies involving miRNA suppression and replacement have been developed. The normalisation of expression and the subsequent impact on AML cells have been investigated for some miRNAs, demonstrating their potential to act as therapeutic targets. Focussing on miRs with therapeutic potential, we have reviewed those that have a significant impact on the aberrant biological processes associated with AML, and crucially, impact leukaemic stem cell survival. We describe six miRNAs in preclinical trials (miR-21, miR-29b, miR-126, miR-181a, miR-223 and miR-196b) and two miRNAs that are in clinical trials (miR-29 and miR-155). However none have been used to treat AML patients and greater efforts are needed to develop miRNA therapies that could benefit AML patients in the future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.